Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals, Inc.verified

AMPE

Price:

$0.25805

Market Cap:

$292.98K

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation; AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19; and AP-018 that is in Phase I clinical trial to treat patients with prolonged...[Read more]

Industry

Biotechnology

IPO Date

2010-03-31

Stock Exchange

OTC

Ticker

AMPE

The Enterprise Value as of January 2026 (TTM) for Ampio Pharmaceuticals, Inc. (AMPE) is -3522021.00

According to Ampio Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -3522021.00. This represents a change of -3.59% compared to the average of -3653091.57 of the last 4 quarters.

Ampio Pharmaceuticals, Inc. (AMPE) Historical Enterprise Value (quarterly & annually)

How has AMPE Enterprise Value performed in the past?

The mean historical Enterprise Value of Ampio Pharmaceuticals, Inc. over the last ten years is 45.96M. The current -3522021.00 Enterprise Value has changed -866.40% with respect to the historical average. Over the past ten years (40 quarters), AMPE's Enterprise Value was at its highest in in the September 2021 quarter at 316.58M. The Enterprise Value was at its lowest in in the March 2014 quarter at -54925068.66.

Quarterly (TTM)
Annual

Average

45.96M

Median

14.97M

Minimum

-36257292.00

Maximum

258.69M

Ampio Pharmaceuticals, Inc. (AMPE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ampio Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 801.70%

Maximum Annual Enterprise Value = 258.69M

Minimum Annual Increase = -224.10%

Minimum Annual Enterprise Value = -36257292.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023-2156550.00-76.78%
2022-9287800.00-111.48%
202180.90M-68.73%
2020258.69M234.15%
201977.42M268.23%
201821.02M-68.85%
201767.49M657.23%
20168.91M-224.10%
2015-7182328.74-80.19%
2014-36257292.00801.70%

Ampio Pharmaceuticals, Inc. (AMPE) Average Enterprise Value

How has AMPE Enterprise Value performed in the past?

The current Enterprise Value of Ampio Pharmaceuticals, Inc. (AMPE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

23.15M

5-year avg

81.11M

10-year avg

45.96M

Ampio Pharmaceuticals, Inc. (AMPE) Enterprise Value vs. Peers

How is AMPE’s Enterprise Value compared to its peers?

Ampio Pharmaceuticals, Inc.’s Enterprise Value is less than Better Therapeutics, Inc. (-854548.00), greater than Calithera Biosciences, Inc. (-23784513.00), less than Oncology Pharma Inc. (767.67K), less than Innovation1 Biotech Inc. (183.64K), greater than Panacos Pharmaceuticals, Inc. (-18548633.00), less than Tengion, Inc. (5.45M), less than Statera Biopharma, Inc. (14.42M), less than Baudax Bio, Inc. (1.86M), less than Arno Therapeutics, Inc. (2.04M), greater than Kaleido Biosciences, Inc. (-16775738.00),

Build a custom stock screener for Ampio Pharmaceuticals, Inc. (AMPE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ampio Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ampio Pharmaceuticals, Inc. (AMPE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ampio Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Ampio Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Ampio Pharmaceuticals, Inc. (AMPE)?

What is the 3-year average Enterprise Value for Ampio Pharmaceuticals, Inc. (AMPE)?

What is the 5-year average Enterprise Value for Ampio Pharmaceuticals, Inc. (AMPE)?

How does the current Enterprise Value for Ampio Pharmaceuticals, Inc. (AMPE) compare to its historical average?